SUNEKOS mã hàng do ALLPARA lưu kho cho mục đích chuyên môn, nhập trực tiếp và có chứng nhận cho mỗi lô giao.
Sunekos Cell 15
Sunekos Cell 15 is an injectable cellulite treatment by Sunekos, developed around the extracellular matrix rather than the fat cell. It is suitable for qualified practitioners treating cellulite, framed as Edematous Fibrosclerotic Panniculopathy, across stages I to IV. The product relies on a synergy of hyaluronic acid, amino acids and an alkaline solution in a non-lipoclastic, non-lipolytic approach and is intended for professional use.
Lợi ích chính của Sunekos Cell 15
- CE-marked Class III medical device
- Promotes optimisation of extracellular matrix protein turnover
- Supports neo-collagenesis rather than collagenase
- Helps improve microcirculation
- Helps reduce fibrosis by re-equilibrating extracellular matrix inflammation
- Helps regulate physiological pH
- Non-invasive, non-lipoclastic and non-lipolytic approach focused on restructuring the extracellular matrix
- Supported by a preliminary study on 25 subjects reporting a reduction in clinical evaluation score in both cellulite stage groups
Chỉ định và sử dụng chuyên môn
Chỉ định chính
- Cellulite, framed as Edematous Fibrosclerotic Panniculopathy (EFP)
- Cellulite stages I and II
- Cellulite stages III and IV
- Fibrosis and extracellular matrix inflammation associated with cellulite
- Impaired microcirculation associated with cellulite
Sử dụng chuyên môn
Sunekos Cell 15 is a CE-marked Class III medical device intended for medical-practitioner use only. It is supplied as a two-component treatment pack that is reconstituted before use, combining low-molecular-weight sodium hyaluronate and amino acids with carbonate/bicarbonate salts.
Vùng điều trị
- Cellulite-affected areas of the thighs and gluteal/trochanteric region
Đối tượng bệnh nhân
Sunekos Cell 15 is intended for adult patients presenting with cellulite / Edematous Fibrosclerotic Panniculopathy (EFP), including stages I–IV. A preliminary clinical evaluation included 25 subjects, with 11 in stages I–II and 14 in stages III–IV.
Cơ chế hoạt động của Sunekos Cell 15
Sunekos Cell 15 works through a synergy of hyaluronic acid, amino acids and an alkaline solution. Where earlier intradermal approaches to cellulite mainly addressed edema and microcirculation, this combination also targets the extracellular matrix: it is designed to optimise extracellular matrix protein turnover, improve microcirculation, reduce fibrosis by re-equilibrating matrix inflammation and help regulate physiological pH. The approach is non-lipoclastic and non-lipolytic, rebuilding rather than destroying, which makes it suitable for restoring skin and adipose tissue homeostasis rather than breaking down fat.
Vì sao nên đặt hàng tại Allpara
Allpara cung cấp sản phẩm SUNEKOS chính hãng, đã được xác minh, từ các nhà cung cấp được tuyển chọn, với khả năng truy xuất lô đầy đủ và hỗ trợ chuyên môn. Chúng tôi phục vụ các phòng khám và chuyên gia thẩm mỹ với sản phẩm đạt chứng nhận CE, giao hàng nhanh khắp EU từ kho tại EU và giá chuyên nghiệp cạnh tranh. Ưu tiên của chúng tôi là sự an toàn, hài lòng và kết quả của bệnh nhân của bạn, cùng dịch vụ hậu mãi tận tâm để bạn hoàn toàn yên tâm.
Câu hỏi thường gặp
Which cellulite stages does Sunekos Cell 15 treat?
Sunekos Cell 15 shows indications for cellulite stages I and II and for stages III and IV, with staging determined by the treating practitioner before treatment.
How does Sunekos Cell 15 differ from lipolytic cellulite treatments?
Sunekos Cell 15 is a non-lipoclastic and non-lipolytic approach. Instead of breaking down fat, it restructures the extracellular matrix, an approach of rebuilding rather than destroying.
Why does Sunekos Cell 15 include an alkaline solution?
The alkaline solution is part of the synergy that helps regulate physiological pH and re-equilibrate extracellular matrix inflammation, which helps reduce the fibrosis component of cellulite.
Thêm sản phẩm từ Professional Dietetics
Lựa chọn thay thế cho phòng khám
Tiếp tục từ nơi bạn dừng lại
Sunekos Cell 15
Sunekos Cell 15 is an injectable cellulite treatment by Sunekos, developed around the extracellular matrix rather than the fat cell. It is suitable for qualified practitioners treating cellulite, framed as Edematous Fibrosclerotic Panniculopathy, across stages I to IV. The product relies on a synergy of hyaluronic acid, amino acids and an alkaline solution in a non-lipoclastic, non-lipolytic approach and is intended for professional use.
Lợi ích chính của Sunekos Cell 15
- CE-marked Class III medical device
- Promotes optimisation of extracellular matrix protein turnover
- Supports neo-collagenesis rather than collagenase
- Helps improve microcirculation
- Helps reduce fibrosis by re-equilibrating extracellular matrix inflammation
- Helps regulate physiological pH
- Non-invasive, non-lipoclastic and non-lipolytic approach focused on restructuring the extracellular matrix
- Supported by a preliminary study on 25 subjects reporting a reduction in clinical evaluation score in both cellulite stage groups
Chỉ định và sử dụng chuyên môn
Chỉ định chính
- Cellulite, framed as Edematous Fibrosclerotic Panniculopathy (EFP)
- Cellulite stages I and II
- Cellulite stages III and IV
- Fibrosis and extracellular matrix inflammation associated with cellulite
- Impaired microcirculation associated with cellulite
Sử dụng chuyên môn
Sunekos Cell 15 is a CE-marked Class III medical device intended for medical-practitioner use only. It is supplied as a two-component treatment pack that is reconstituted before use, combining low-molecular-weight sodium hyaluronate and amino acids with carbonate/bicarbonate salts.
Vùng điều trị
- Cellulite-affected areas of the thighs and gluteal/trochanteric region
Đối tượng bệnh nhân
Sunekos Cell 15 is intended for adult patients presenting with cellulite / Edematous Fibrosclerotic Panniculopathy (EFP), including stages I–IV. A preliminary clinical evaluation included 25 subjects, with 11 in stages I–II and 14 in stages III–IV.
Cơ chế hoạt động của Sunekos Cell 15
Sunekos Cell 15 works through a synergy of hyaluronic acid, amino acids and an alkaline solution. Where earlier intradermal approaches to cellulite mainly addressed edema and microcirculation, this combination also targets the extracellular matrix: it is designed to optimise extracellular matrix protein turnover, improve microcirculation, reduce fibrosis by re-equilibrating matrix inflammation and help regulate physiological pH. The approach is non-lipoclastic and non-lipolytic, rebuilding rather than destroying, which makes it suitable for restoring skin and adipose tissue homeostasis rather than breaking down fat.
Vì sao nên đặt hàng tại Allpara
Allpara cung cấp sản phẩm SUNEKOS chính hãng, đã được xác minh, với khả năng truy xuất lô đầy đủ, hàng đạt chứng nhận CE, giao hàng nhanh khắp EU và hỗ trợ hậu mãi chuyên nghiệp.
Câu hỏi thường gặp
Which cellulite stages does Sunekos Cell 15 treat?
Sunekos Cell 15 shows indications for cellulite stages I and II and for stages III and IV, with staging determined by the treating practitioner before treatment.
How does Sunekos Cell 15 differ from lipolytic cellulite treatments?
Sunekos Cell 15 is a non-lipoclastic and non-lipolytic approach. Instead of breaking down fat, it restructures the extracellular matrix, an approach of rebuilding rather than destroying.
Why does Sunekos Cell 15 include an alkaline solution?
The alkaline solution is part of the synergy that helps regulate physiological pH and re-equilibrate extracellular matrix inflammation, which helps reduce the fibrosis component of cellulite.